Adelene Q Perkins is a director of Bruker Corp.
Person profile
Roles
Bruker
Director
Infinity Pharmaceuticals
Director
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BRUKER CORP
9 Jan 24
4
INFINITY PHARMACEUTICALS, INC.
12 Sep 23
4
BRUKER CORP
9 Jan 23
4
INFINITY PHARMACEUTICALS, INC.
12 Jan 22
4
BRUKER CORP
6 Jan 22
4
BRUKER CORP
7 Jan 21
4
INFINITY PHARMACEUTICALS, INC.
23 Dec 20
4
INFINITY PHARMACEUTICALS, INC.
13 Jan 20
4
BRUKER CORP
7 Jan 20
4
INFINITY PHARMACEUTICALS, INC.
14 Jun 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | BRKR Bruker | Common Stock | Grant | Acquire A | No | No | 0 | 2,377 | 0.00 | 21,326 |
12 Sep 23 | INFIQ Infinity Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 0.07 | 410,196 | 28.71 k | 1,175,291 |
9 Sep 23 | INFIQ Infinity Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 768,133 | 0.00 | 1,585,487 |
9 Sep 23 | INFIQ Infinity Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 768,133 | 0.00 | 0 |
5 Jan 23 | BRKR Bruker | Common Stock | Grant | Acquire A | No | No | 0 | 1,970 | 0.00 | 18,949 |